Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490763 · ClinicalTrials.gov registry record
Active Surveillance in Prostate Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,139
- Enrollment target
NCT00490763: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00490763 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490763 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,139 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if men who have a type of prostate cancer that has been classified as "low risk" can safely not be treated for the disease. Doctors want to know if patients with "low risk" cancer can avoid or postpone therapy and the related side effects and still live as long as patients who immediately receive therapy. This is an investigational study. There are no medications used in this trial. About 1,000 patients will take part in this study. All will be enrolled at MD Anderson.
Primary Outcome
Primary end point of the study is time to disease progression, where progression is defined by pathologic criteria and/or an increase in tPSA value.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2006-02-13 |
| Est. Completion | 2021-09-06 |
What the finished NCT00490763 record still lists
NCT00490763 is an observational study that tracks outcomes without assigning an intervention. Its 1,139 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT00490763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00490763 about?
NCT00490763 is a clinical study titled "Active Surveillance in Prostate Cancer". The goal of this clinical research study is to find out if men who have a type of prostate cancer that has been classified as "low risk" can safely not be treated for the disease. Doctors want to know if patients with "low risk" cancer can avoid or postpone therapy and the related side effects and s...
What is the current status of trial NCT00490763?
This trial is currently completed. The enrollment target is 1,139 participants. The study started on 2006-02-13. Estimated completion is 2021-09-06.
What interventions are being tested in trial NCT00490763?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00490763?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI